Heart Failure Drugs Market

Heart failure occurs when your heart muscle doesn't pump blood as well as it should.

Heart Failure Drugs Market contains market size and forecasts of Heart Failure Drugs in global, including the following market information:

Global Heart Failure Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Heart Failure Drugs Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Heart Failure Drugs companies in 2021 (%)

The global Heart Failure Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ACEI Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Heart Failure Drugs include Novartis, Pfizer, AstraZeneca, Hikma, Teva, Cipla, Merck & Co., Amgen and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Heart Failure Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Heart Failure Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Heart Failure Drugs Market Segment Percentages, by Type, 2021 (%)

• ACEI
• Angiotensin II Receptor Blockers
• ARNIs
• Beta Blockers
• Aldosterone Antagonists
• Diuretics

Global Heart Failure Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Heart Failure Drugs Market Segment Percentages, by Application, 2021 (%)

• Reduced Ejection Fraction
• Preserved Ejection Fraction

Global Heart Failure Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Heart Failure Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Heart Failure Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Heart Failure Drugs revenues share in global market, 2021 (%)
• Key companies Heart Failure Drugs sales in global market, 2017-2022 (Estimated), (MT)
• Key companies Heart Failure Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Pfizer
• AstraZeneca
• Hikma
• Teva
• Cipla
• Merck & Co.
• Amgen
• Roche
• Sun Pharma
• Mylan